Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial compared veliparib, carboplatin and paclitaxel with standard chemotherapy for non small cell lung cancer (NSCLC). It was for people with non squamous NCSLC.
People could join the trial between 2014 and 2016. The team published the results in 2022.
Recruitment start: 17 September 2014
Recruitment end: 21 July 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Alastair Greystoke
AbbVie Inc
NIHR Clinical Research Network: Cancer
Last reviewed: 24 Jul 2026
CRUK internal database number: 13061